Early drug development and evaluation of putative antitubercular compounds in the-omics era

A Minias, L Żukowska, E Lechowicz, F Gąsior… - Frontiers in …, 2021 - frontiersin.org
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium
tuberculosis. According to the WHO, the disease is one of the top 10 causes of death of …

Comparative Genome and Network Centrality Analysis to Identify Drug Targets of Mycobacterium tuberculosis H37Rv

T Melak, S Gakkhar - BioMed research international, 2015 - Wiley Online Library
Potential drug targets of Mycobacterium tuberculosis H37Rv were identified through
systematically integrated comparative genome and network centrality analysis. The …

Identification and architecture of a putative secretion tube across mycobacterial outer envelope

X Cai, L Liu, C Qiu, C Wen, Y He, Y Cui, S Li… - Science …, 2021 - science.org
Tuberculosis-causing mycobacteria have thick cell-wall and capsule layers that are formed
from complex structures. Protein secretion across these barriers depends on a specialized …

An in silico approach to identify potential inhibitors against multiple drug targets of Mycobacterium tuberculosis

S Kumar, P Sahu, L Jena - The International Journal of …, 2019 - journals.lww.com
Background: The increasing incidence of multidrug-resistant cases of tuberculosis (TB) and
difficulty in treating these cases requires an urgent need to find an effective anti-TB drug …

Integrating Multifaceted Information to Predict Mycobacterium tuberculosis-Human Protein-Protein Interactions

J Sun, LL Yang, X Chen, DX Kong… - Journal of proteome …, 2018 - ACS Publications
Tuberculosis (TB) is one of the biggest infectious disease killers caused by Mycobacterium
tuberculosis (MTB). Studying the protein-protein interactions (PPIs) between MTB and …

Comparative analysis of Rosetta stone events in Klebsiella pneumoniae and Streptococcus pneumoniae for drug target identification

P Ramesh, JH Nagendrappa… - Beni-Suef University …, 2021 - Springer
Background Drug target identification is a fast-growing field of research in many human
diseases. Many strategies have been devised in the post-genomic era to identify new drug …

Maximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein-protein interaction network

T Melak, S Gakkhar - Clinical and translational medicine, 2015 - Springer
Background In spite of the implementations of several strategies, tuberculosis (TB) is
overwhelmingly a serious global public health problem causing millions of infections and …

Structural analysis of protein translocase subunit SecY from Mycobacterium tuberculosis H37Rv: a potential target for anti-tuberculosis drug discovery

TM Sitote, S Gakkhar - International Journal of …, 2017 - inderscienceonline.com
Identification of noble drug targets is a very important step in the development of anti-
mycobacterial drugs to counter the problem of drug resistance. The availability of structural …

Genome scale identification, structural analysis, and classification of periplasmic binding proteins from Mycobacterium tuberculosis

P Sandhu, M Kumari, K Naini, Y Akhter - Current Genetics, 2017 - Springer
Periplasmic-binding proteins occupy the periplasmic space of bacteria and are involved in
binding and transport of various ions, siderophores, and other diverse types of solutes …

[PDF][PDF] Topological Characterization of Protein-Protein Interaction via Implementing Large Scale Interaction Networks in Mycobacterium Tuberculosis H37Rv

F Deeba, S Pandey, G Verma, V Dwivedi - 2020 - researchgate.net
This research manuscript essentially emphasizes the retrieval of Mycobacterium
Tuberculosis H37Rv SuperTarget proteins to provide STRING Database with network …